BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37902917)

  • 1. Cardiovascular Risk Assessment and Control in Outpatients Evaluated by 24-hour Ambulatory Blood Pressure and Different LDL-C Equations.
    Landolfo M; Allevi M; Spannella F; Giulietti F; Gezzi A; Sarzani R
    High Blood Press Cardiovasc Prev; 2023 Nov; 30(6):551-560. PubMed ID: 37902917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of ESC/ESH-Based Written Generic Lifestyle Advice and a Nutraceutical on 24-Hour Blood Pressure in Patients with High-Normal Office Blood Pressure and Low-Moderate Cardiovascular Risk.
    Landolfo M; Spannella F; Poliseno C; Massacesi A; Giulietti F; Festa R; Cavazzin E; Sasso G; Mazza A; Sarzani R
    Nutrients; 2023 Dec; 15(24):. PubMed ID: 38140359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Novel Equations for Estimating Low-Density Lipoprotein Cholesterol in Patients Undergoing Coronary Angiography.
    Zafrir B; Saliba W; Flugelman MY
    J Atheroscler Thromb; 2020 Dec; 27(12):1359-1373. PubMed ID: 32612027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.
    Sajja A; Park J; Sathiyakumar V; Varghese B; Pallazola VA; Marvel FA; Kulkarni K; Muthukumar A; Joshi PH; Gianos E; Hirsh B; Mintz G; Goldberg A; Morris PB; Sharma G; Blumenthal RS; Michos ED; Post WS; Elshazly MB; Jones SR; Martin SS
    JAMA Netw Open; 2021 Oct; 4(10):e2128817. PubMed ID: 34709388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performance of equations to estimate low-density lipoprotein cholesterol levels and cardiovascular disease incidence: The ATTICA study (2002-2022).
    Nomikos T; Georgoulis M; Chrysohoou C; Damigou E; Barkas F; Skoumas I; Liberopoulos E; Pitsavos C; Tsioufis C; Sfikakis PP; Tselepis A; Panagiotakos DB
    Lipids; 2023 Jul; 58(4):159-170. PubMed ID: 37153959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Novel Web-Based Application HUMTELEMED for a Comprehensive Assessment of Cardiovascular Risk Based on the 2021 European Society of Cardiology Guidelines.
    Landolfo M; Spannella F; Gezzi A; Giulietti F; Sabbatini L; Bari I; Alessandroni R; Di Agostini A; Turri P; Alborino F; Scoppolini Massini L; Sarzani R
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673568
    [No Abstract]   [Full Text] [Related]  

  • 7. Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis.
    Sajja A; Li HF; Spinelli KJ; Blumenthal RS; Virani SS; Martin SS; Gluckman TJ
    J Am Coll Cardiol; 2022 Feb; 79(6):530-541. PubMed ID: 35144744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP.
    Matsushita K; Kaptoge S; Hageman SHJ; Sang Y; Ballew SH; Grams ME; Surapaneni A; Sun L; Arnlov J; Bozic M; Brenner H; Brunskill NJ; Chang AR; Chinnadurai R; Cirillo M; Correa A; Ebert N; Eckardt KU; Gansevoort RT; Gutierrez O; Hadaegh F; He J; Hwang SJ; Jafar TH; Jassal SK; Kayama T; Kovesdy CP; Landman GW; Levey AS; Lloyd-Jones DM; Major RW; Miura K; Muntner P; Nadkarni GN; Nowak C; Ohkubo T; Pena MJ; Polkinghorne KR; Sairenchi T; Schaeffner E; Schneider MP; Shalev V; Shlipak MG; Solbu MD; Stempniewicz N; Tollitt J; Valdivielso JM; van der Leeuw J; Wang AY; Wen CP; Woodward M; Yamagishi K; Yatsuya H; Zhang L; Dorresteijn JAN; Di Angelantonio E; Visseren FLJ; Pennells L; Coresh J
    Eur J Prev Cardiol; 2023 Jan; 30(1):8-16. PubMed ID: 35972749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of estimating low-density lipoprotein cholesterol (LDL-C) using different equations in the general population.
    Lam R; Manemann SM; Seehusen KE; Remaley AT; Sauver JLS; Jiang R; Killian JM; Sampson M; Meeusen JW; Decker PA; Roger VL; Takahashi PY; Larson NB; Bielinski SJ
    Lipids Health Dis; 2024 Jul; 23(1):210. PubMed ID: 38965543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.
    Samuel C; Park J; Sajja A; Michos ED; Blumenthal RS; Jones SR; Martin SS
    Glob Heart; 2023; 18(1):36. PubMed ID: 37361322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
    Vallejo-Vaz AJ; Bray S; Villa G; Brandts J; Kiru G; Murphy J; Banach M; De Servi S; Gaita D; Gouni-Berthold I; Kees Hovingh G; Jozwiak JJ; Jukema JW; Gabor Kiss R; Kownator S; Iversen HK; Maher V; Masana L; Parkhomenko A; Peeters A; Clifford P; Raslova K; Siostrzonek P; Romeo S; Tousoulis D; Vlachopoulos C; Vrablik M; Catapano AL; Poulter NR; Ray KK;
    Cardiovasc Drugs Ther; 2023 Oct; 37(5):941-953. PubMed ID: 35567726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of low-density lipoprotein cholesterol equations by cross-platform assessment of accuracy-based EQA data against SI-traceable reference value.
    Tan HT; Yong S; Liu H; Liu Q; Teo TL; Sethi SK
    Clin Chem Lab Med; 2023 Sep; 61(10):1808-1819. PubMed ID: 37013650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
    Mulas O; Abruzzese E; Luciano L; Iurlo A; Attolico I; Castagnetti F; Galimberti S; Bonifacio M; Annunziata M; Gozzini A; Orlandi EM; Stagno F; Binotto G; Pregno P; Fozza C; Loi M; Trawinska MM; De Gregorio F; Cattaneo D; Albano F; Iezza M; Baratè C; Scaffidi L; Elena C; Giai V; Scalzulli E; Breccia M; La Nasa G; Caocci G
    Ann Hematol; 2024 Feb; 103(2):427-436. PubMed ID: 38012435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.
    Palmer MK; Barter PJ; Lundman P; Nicholls SJ; Toth PP; Karlson BW
    Clin Biochem; 2019 Feb; 64():24-29. PubMed ID: 30365923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk assessment among patients with hypertension based on SCORE2 and SCORE-OP algorithms in black Africans].
    Yao H; Ekou A; Ehouman E; Guezo M; Soya E; Kouadio D; Touré C; Kipenge R; Koffi D; N'Guetta R
    Ann Cardiol Angeiol (Paris); 2023 Jun; 72(3):101602. PubMed ID: 37187110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCORE2 Screening Tool for Cardiovascular Risk Assessment in Psoriasis-A Case-Control Study.
    Kampe T; Baloghová J; Kolarčik P; Rimárová K; Dorko E
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892947
    [No Abstract]   [Full Text] [Related]  

  • 19. An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation.
    Coverdell TC; Sampson M; Zubirán R; Wolska A; Donato LJ; Meeusen JW; Jaffe AS; Remaley AT
    Lipids Health Dis; 2024 Feb; 23(1):43. PubMed ID: 38331834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
    Naser N; Dzubur A; Durak A; Kulic M; Naser N
    Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.